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OBJECTIVE — Although magnesium may favorably affect metabolic outcomes, few studies
have investigated the role of magnesium intake in systemic inﬂammation and endothelial dys-
function in humans.
RESEARCH DESIGN AND METHODS — Among 3,713 postmenopausal women aged
50–79 years in the Women’s Health Initiative Observational Study and free of cardiovascular
disease, cancer, and diabetes at baseline, we measured plasma concentrations of high-sensitivity
C-reactive protein (hs-CRP), interleukin-6 (IL-6), turnor necrosis factor- receptor 2 (TNF--
R2), soluble intercellular adhesion molecule-1 (sICAM-1), soluble vascular cell adhesion mole-
cule-1(sVCAM-1),andE-selectin.Magnesiumintakewasassessedusingasemiquantitativefood
frequency questionnaire.
RESULTS — Afteradjustmentforage,ethnicity,clinicalcenter,timeofblooddraw,smoking,
alcohol, physical activity, energy intake, BMI, and diabetes status, magnesium intake was in-
versely associated with hs-CRP (P for linear trend  0.003), IL-6 (P  0.0001), TNF--R2 (P 
0.0006), and sVCAM-1 (P  0.06). Similar ﬁndings remained after further adjustment for
dietary ﬁber, fruit, vegetables, folate, and saturated and trans fat intake. Multivariable-
adjusted geometric means across increasing quintiles of magnesium intake were 3.08, 2.63,
2.31, 2.53, and 2.16 mg/l for hs-CRP (P  0.005); 2.91, 2.63, 2.45, 2.27, and 2.26 pg/ml
for IL-6 (P  0.0005); and 707, 681, 673, 671, and 656 ng/ml for sVCAM-1 (P  0.04). An
increase of 100 mg/day magnesium was inversely associated with hs-CRP (0.23 mg/l 
0.07; P  0.002), IL-6 (0.14  0.05 pg/ml; P  0.004), TNF--R2 (0.04  0.02 pg/ml;
P  0.06), and sVCAM-1 (0.04  0.02 ng/ml; P  0.07). No signiﬁcant ethnic differences
were observed.
CONCLUSIONS — High magnesium intake is associated with lower concentrations of
certain markers of systemic inﬂammation and endothelial dysfunction in postmenopausal
women.
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M
agnesium is a biologically active
mineral that acts as a cofactor in
hundreds of enzymatic reactions
inthehumanbody.Inobservationalstud-
ies, magnesium intake has been inversely
associated with metabolic disease out-
comes including hypertension (1), type 2
diabetes (2), cardiovascular disease (3),
and colorectal cancer (4). The biological
mechanism underlying these relations is
not entirely clear, although experimental
data in animals indicate that dietary mag-
nesium deﬁciency may promote an in-
ﬂammatory response (5), ultimately
leading to endothelial dysfunction and
metabolic disease. Available data in hu-
mansalsosuggestthatlowmagnesiumin-
take may be related to dyslipidemia (1)
and insulin resistance (2). Although mag-
nesium intake has been inversely associ-
ated with high-sensitivity C-reactive
protein (hs-CRP) (1,6) in white women,
its associations with interleukin-6 (IL-6)
and tumor necrosis factor (TNF)- (6,7)
have been inconsistent. In addition, ev-
idence regarding the relation of magne-
sium intake to endothelial dysfunction
as measured by elevated concentrations
of adhesion molecules is limited (6,8).
Studies assessing dietary magnesium in-
take in relation to inﬂammation and en-
dothelialmarkersinminoritypopulations
arelacking,anditisnotknownwhether
there are ethnic differences modifying
this relation.
We therefore examined comprehen-
sively the association between dietary
magnesium intake and circulating con-
centrations of biomarkers of systemic in-
ﬂammation (hs-CRP, IL-6, and TNF-
receptor 2 [TNF--R2]) and endothelial
dysfunction (soluble intercellular adhe-
sion molecule-1 [sICAM-1], soluble vas-
cular cell adhesion molecule-1 [sVCAM-
1],andE-selectin)inanethnicallydiverse
cohort of postmenopausal women aged
50–79 years enrolled in the Women’s
Health Initiative Observational Study
(WHI-OS), including whites, African
American, Hispanics, and Asians/Paciﬁc
Islanders.
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METHODS— The WHI-OS is an on-
going national health study designed to
examine demographic, lifestyle, dietary,
and biological factors on health outcomes
among postmenopausal women. Details
on design and recruitment have been
published elsewhere (9,10). In brief, a to-
tal of 93,676 postmenopausal women
aged 50–79 years were enrolled in the
WHI-OS between September 1994 and
December 1998 from 40 clinical centers
nationwide. Eligible participants com-
pleted baseline demographic and dietary
questionnaires, underwent physical ex-
aminations, and provided fasting blood
samples. All WHI study procedures
were approved by human subject re-
view at each clinical center, and all
women provided informed consent be-
fore participating.
Forthecurrentstudy,weincludedall
participants from a case-control study
of type 2 diabetes nested within the
WHI-OS (n  3,713), because all were
free of cardiovascular disease, type 2 dia-
betes, and cancers at baseline. Details of
this diabetes ancillary study have been
published elsewhere (11,12).
Baseline measurements
Certiﬁed WHI trained staff measured
height, weight, hip circumference, and
blood pressure at the baseline visit. BMI
(measuredasweightinkilogramsdivided
by the square of height in meters) was
calculated. Standardized questionnaires
including information on age, ethnicity,
education, income, occupation, medical
and family history, smoking status, alco-
holuse,recreationalphysicalactivity,and
medication and supplement use were ad-
ministered. A semiquantitative food
frequency questionnaire (FFQ) used pre-
viously among similar populations
(13,14) was used to assess food and nu-
trient intake in the last 3 months. The nu-
trient database for the WHI FFQ was
derived from the University of Minnesota
Nutrition Coding Center (Minneapolis,
MN) nutrient database (15). All dietary
nutrient variables were adjusted for total
energy intake using the residual method
(16). The energy-adjusted correlation co-
efﬁcient for dietary magnesium intake
comparingtheFFQwith8daysofdietary
intake (four 24-h recalls and a 4-day food
record) among the WHI postmenopausal
femalepopulationwasreportedtobe0.7,
indicating that the WHI FFQ reasonably
captures short-term intake of dietary
magnesium in this population (17).
Blood collection and assessment of
biomarkers
Fasting blood specimens were collected
fromallparticipantsatbaselineaccording
toastandardizedprotocol.Aliquotsofse-
rum, plasma, and buffy coat were frozen
and shipped on dry ice to a central repos-
itory and stored at 70°C for future as-
says in outside laboratories. hs-CRP was
measured on a chemistry analyzer (Hita-
chi 911; Roche Diagnostics, Indianapolis,
IN) using an immunoturbidimetric assay
with reagents and calibrators (Denka
Seiken, Niigata, Japan). IL-6 was mea-
sured by an ultrasensitive enzyme-linked
immunosorbent assay (R&D Systems,
Minneapolis, MN). TNF--R2, sICAM-1,
sVCAM-1, and E-selectin were measured
by an enzyme-linked immunosorbent as-
say (R&D Systems). The coefﬁcients of
variation for each analyte were 1.61% for
hs-CRP, 7.6% for IL-6, 3.5% for TNF-
-R2 (11), 6.7% for sICAM-1, 8.9% for
sVCAM-1, and 6.5% for E-selectin (12).
Statistical analysis
The distributions of hs-CRP, IL-6, TNF-
-R2,sICAM-1,sVCAM-1,andE-selectin
were highly skewed, and thus log trans-
formations were performed to achieve
normal distributions. Multiple linear re-
gressionmodels(usingPROCGLM)were
used to compute geometric means of in-
ﬂammatory and endothelial biomarkers
across quintiles of dietary magnesium af-
ter adjustment for potential confounding
variables. Geometric means were calcu-
lated by regressing the natural logarith-
mic values of the plasma concentration of
inﬂammatoryandendothelialbiomarkers
on dietary magnesium intake and taking
the antilog of the resulting mean logarith-
mic value. Tests of linear trend across in-
creasing quintiles of dietary magnesium
intake were conducted by using the
median value of each quintile as a contin-
uous variable in the model. Regression
coefﬁcients for the change in inﬂamma-
toryandendothelialbiomarkersforanin-
crease of 100 mg/day dietary magnesium
stratiﬁedbyethnicitywerealsocalculated
using linear regression models. All multi-
variable models were adjusted for match-
ing factors (age, ethnicity [white, African
American, Hispanic/Latino, and Asian/
Paciﬁc Islander], clinical center, and time
of blood draw), smoking status (never,
past, and current), alcohol (never, past,
and current drinkers), physical activity
measured by expenditure of energy from
recreational activity (continuous), total
energy intake (continuous), BMI (contin-
uous), and type 2 diabetes case-control
status (case and control subjects). To spe-
ciﬁcally address the independent associa-
tion of magnesium intake, the ﬁnal
multivariate models were further ad-
justed for dietary ﬁber intake and other
dietary factors such as fruit (continuous),
vegetable (continuous), folate (continu-
ous),transfat(continuous),andsaturated
fat(continuous)intake.Varianceinﬂation
factors were examined for all models to
check for multicollinearity issues. To fur-
ther assess potential effect modiﬁcation,
subgroup analyses with prespeciﬁed fac-
tors including ethnicity (white, African
American, Hispanic/Latino, and Asian/
Paciﬁc Islander), BMI (25 and 25
kg/m
2), smoking status (never smokers
andeversmokers[currentandpastsmok-
ers]), alcohol intake (nondrinkers and
currentdrinkers),anddietaryﬁberintake
(low ﬁber intake [21 g/day] and high
ﬁber intake [21 g/day]) were con-
ducted. The Wald test was used to assess
the signiﬁcance of multiplicative interac-
tion terms. To account for measurement
error, we further conducted a deattenua-
tionanalysisusingaregressioncoefﬁcient
relating the dietary magnesium measure-
ment from the baseline FFQ to 8 days of
food records obtained from 113 women
in the WHI (17,18).
All P values were two-tailed, and P 
0.05 was considered to indicate statistical
signiﬁcance unless otherwise speciﬁed.
Allstatisticalanalyseswereconductedus-
ing SAS software (version 9.1; SAS Insti-
tute, Cary, NC).
RESULTS— Characteristics of partici-
pants are summarized in Table 1. On av-
erage, African Americans had a higher
BMI, higher smoking rate, higher dietary
fat intake, and lower intake of dietary ﬁ-
ber and total magnesium than women in
other ethnic groups. Asian/Paciﬁc Island-
ers had lower concentrations of hs-CRP,
IL-6,TNF--R2,sICAM-1,andE-selectin
than did other ethnic groups, whereas Af-
rican Americans had higher concentra-
tions of hs-CRP and IL-6.
Higherdietarymagnesiumintakewas
signiﬁcantly associated with lower con-
centrations of inﬂammatory biomarkers
including hs-CRP (P for linear trend 
0.003), IL-6 (P for linear trend 
0.0001), and TNF--R2 (P for linear
trend  0.0006) (Table 2). Further ad-
justment for dietary ﬁber intake attenu-
ated but did not alter the linear trends for
hs-CRP (P for linear trend  0.009), IL-6
(P for linear trend  0.0005), and TNF-
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relation to magnesium intake. After addi-
tionally controlling for fruit and vegeta-
ble, folate, and saturated and trans fat
intake, dietary magnesium intake re-
mained signiﬁcantly associated with hs-
CRP and IL-6. Multivariable adjusted
geometric means across increasing quin-
tiles of dietary magnesium were 3.08,
2.63, 2.31, 2.53, and 2.16 mg/l for hs-
CRP (P for linear trend  0.005) and
2.91,2.63,2.45,2.27,and2.26pg/mlfor
IL-6 (P for linear trend  0.0005).
Similarly, we observed signiﬁcant
trends of an inverse association of dietary
magnesium intake with concentrations of
sVCAM-1 (P for linear trend  0.06) and
E-selectin (P for linear trend  0.0007)
(Table 2). After further adjustment for di-
etary ﬁber intake, the inverse association
withsVCAM-1remainedstrong(Pforlin-
eartrend0.05)andtheassociationwith
E-selectin was diminished. After addi-
tional adjustment for dietary factors, only
sVCAM-1 remained signiﬁcantly associ-
atedwithdietarymagnesiumintake;mul-
tivariable-adjusted geometric means of
sVCAM-1 across increasing quintiles of
dietary magnesium were 707, 681, 673,
671, and 656 ng/ml (P for linear trend 
0.04). Tests of variance inﬂation indi-
cated no serious multicollinearity issues
in the models (variance inﬂation factor
5 for all models).
Assuming a linear relation, an incre-
ment of 100 mg/day in dietary magne-
sium intake was inversely associated with
hs-CRP ( 0.23  0.07; P  0.002)
and IL-6 ( 0.14  0.05; P  0.004)
(model 3) (Table 3). After correction for
measurement error, the association was
strengthened for both hs-CRP (
0.31  0.10) and IL-6 ( 0.19 
0.07) (data not shown). There was a sug-
gestion that the association of dietary
magnesium with hs-CRP concentration
varied by ethnicity, with strong associa-
tions among white and African American
women but no associations among His-
panic and Asian-Paciﬁc Islander women
(Pinteraction  0.05). Inverse associations of
dietary magnesium with IL-6 concentra-
tion were observed in each ethnicity,
without statistical evidence of heteroge-
neity (Pinteraction  0.77). Compared with
those in normal-weight women (BMI
25 kg/m
2), concentrations of hs-CRP
and IL-6 were signiﬁcantly higher among
overweight and obese women (BMI 25
kg/m
2), and inverse correlations with di-
etary magnesium were more pronounced
(Fig. 1A and B). Similarly, in subgroup
analyses stratiﬁed by smoking status (Fig.
1C and D), concentrations of hs-CRP and
IL-6 were higher and demonstrated a
stronger inverse association among ever
smokers than never smokers (P for linear
trend among ever smokers: hs-CRP P 
0.01andIL-6P0.0008).Testsofinter-
action were also signiﬁcant for alcohol in-
take (IL-6 P  0.04 and E-selectin P 
0.008) and dietary ﬁber intake (TNF-
-R2 P  0.05).
CONCLUSIONS — In this large, eth-
nically diverse cohort of postmenopausal
women, dietary magnesium intake was
inversely associated with plasma concen-
trations of hs-CRP, IL-6, TNF--R2,
sVCAM-1, and E-selectin independent of
known risk factors for metabolic out-
comes. Adjustment for dietary ﬁber in-
take attenuated but did not signiﬁcantly
alter these associations except in the case
of E-selectin. After further adjustment for
fruit and vegetable intake, folate intake,
and saturated and trans fat intake, these
Table 1—Baseline characteristics according to ethnicity among postmenopausal women in the WHI-OS
Race/ethnicity
White
African
American
Hispanic/
Latino
Asian/Paciﬁc
Islander
n 1,922 1,123 423 245
Mean age (years) 64  6.9 61.0  6.7 60  6.8 64  7.6
Mean BMI (kg/m
2) 29  6.7 31  7.1 29  5.8 25  4.5
Current smoker (%) 6 12 5 4
Current drinker (%) 69 51 51 40
Total energy expenditure from recreational
physical activity (METs/week) 12  13.3 11  13.5 11  14.9 14  14.4
Current postmenopausal hormone use (%) 43 31 42 50
Nutrient intakes
Carbohydrate (% of energy) 52  9.4 52  9.9 53  10.1 56  8.5
Protein (% of energy) 17  3.3 16  3.5 16  3.6 16  3.1
Fat (% of energy) 31  8.5 33  8.5 31  9.6 29  7.6
Dietary ﬁber (g/day) 17  7.0 14  7.1 16  7.8 15  6.5
Total magnesium intake (mg/day)* 335  198 261  170 279  191 277  152
Dietary magnesium intake (mg/day)† 263  100 222  140 229  127 219  96
Markers of inﬂammation
hs-CRP (mg/l) 5.01  7.2 5.91  15.4 4.66  5.5 2.11  3.95
IL-6 (pg/ml) 3.26  5.0 3.68  4.58 3.14  3.67 2.87  6.24
TNF--R2 (pg/ml) 2,785  871 2,423  819 2,517  767 2,292  688
Markers of endothelial dysfunction
sICAM-1 (ng/ml) 328  94 270  106 319  103 255  79
sVCAM-1 (ng/ml) 819  278 639  224 738  301 690  243
E-selectin (ng/ml) 47.0  28.1 45.4  24.5 48.7  28.1 40.2  23.5
Data are means SD unless otherwise indicated. n  3,713. *Total magnesium intake includes intake from dietary and supplemental sources. †Dietary magnesium
includes intake from diet alone. MET, metabolic equivalent.
Dietary magnesium and inﬂammation in women
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CRP, IL-6, and sVCAM-1, suggesting that
dietary magnesium may inﬂuence con-
centrations of these biomarkers indepen-
dently of other dietary factors associated
with inﬂammation.
Our ﬁndings support the notion that
magnesium intake improves systemic in-
ﬂammation and endothelial dysfunction
and may play a role in the prevention of
type 2 diabetes and metabolic syndrome,
a longstanding relation with causality yet
tobeconﬁrmed.Thesedataareconsistent
with a considerable body of experimental
evidence in animals suggesting that acute
magnesium deﬁciency leads to an inﬂam-
matory response (5). Observational data
in humans provide additional support for
this relation. To date, several cross-
sectional studies have reported a link be-
tweenbothlowdietarymagnesiumintake
(1,6) and serum magnesium concentra-
tions (19) and elevated hs-CRP in white
populations.Fiberintakeanddietarypat-
terns high in magnesium were also
inversely associated with hs-CRP concen-
trations in the Nurses’ Health Study (8)
and in NHANES 1999–2000 (20). How-
ever, the relation of magnesium intake to
IL-6 and TNF- is less clear. No associa-
tion was reported between dietary mag-
nesium intake and TNF--R2 or IL-6 in
the Nurses’ Health Study (6). However, a
“western” dietary pattern, lower in mag-
nesium-containingfoods,wasfoundtobe
associated with elevated IL-6 and other
markers of inﬂammation and endothelial
dysfunction (8). Our ﬁndings provide ev-
idence that hs-CRP and IL-6 may serve as
sensitive markers of inﬂammation that
may directly beneﬁt from increased mag-
nesium intake through dietary sources.
CRP is an acute-phase reactant se-
creted by the liver in response to inﬂam-
matory cytokines including IL-6 and
TNF-andisanindependentpredictorof
cardiovascular disease (21) and type 2 di-
abetes (11). IL-6 and TNF- are proin-
ﬂammatory cytokines secreted by
macrophages and T-cells to stimulate an
immune response to trauma. Low plasma
magnesium concentrations and the sub-
sequent disruption in intracellular mag-
nesium homeostasis may play a role in
activating the inﬂammatory response
(22). Because hs-CRP is a more sensitive
and robust marker of systemic inﬂamma-
tion than other inﬂammatory markers
(23),itmaybemorereadilydetected.Our
ﬁndingsalsosuggestthatIL-6maybesen-
sitive to ﬂuctuations in dietary intake of
magnesium. Although TNF--R2, a cell
surface receptor believed to modulate the
Table 2—Mean plasma concentrations of biomarkers of inﬂammation by quintile of dietary magnesium intake among postmenopausal women
in the WHI-OS
Dietary magnesium P for linear
trend Q1 Q2 Q3 Q4 Q5
Median
(mg/day) 168.5 204.4 233.2 263.1 310.2
hs-CRP (mg/l)
Model 1* 2.89 (2.59–3.23) 2.58 (2.31–2.87) 2.31 (2.07–2.58) 2.60 (2.31–2.92) 2.29 (2.03–2.58) 0.003
Model 2† 2.99 (2.61–3.41) 2.61 (2.33–2.92) 2.32 (2.07–2.59) 2.57 (2.28–2.90) 2.23 (1.96–2.55) 0.009
Model 3‡ 3.08 (2.67–3.55) 2.63 (2.34–2.94) 2.31 (2.07–2.59) 2.53 (2.24–2.86) 2.16 (1.87–2.50) 0.005
IL-6 (pg/ml)
Model 1* 2.91 (2.70–3.13) 2.63 (2.45–2.83) 2.46 (2.28–2.64) 2.28 (2.11–2.46) 2.27 (2.10–2.46) 0.0001
Model 2† 2.86 (2.62–3.13) 2.62 (2.43–2.82) 2.45 (2.28–2.64) 2.29 (2.11–2.48) 2.30 (2.11–2.51) 0.0005
Model 3‡ 2.91 (2.64–3.19) 2.63 (2.44–2.84) 2.45 (2.27–2.64) 2.27 (2.09–2.46) 2.26 (2.05–2.49) 0.0005
TNF--R2
(pg/ml)
Model 1* 2,461 (2,392–2,532) 2,506 (2,437–2,577) 2,426 (2,357–2,497) 2,424 (2,352–2,498) 2,338 (2,267–2,411) 0.0006
Model 2† 2,429 (2,347–2,514) 2,493 (2,422–2,566) 2,423 (2,354–2,494) 2,434 (2,360–2,510) 2,361 (2,282–2,443) 0.10
Model 3‡ 2,422 (2,335–2,513) 2,493 (2,421–2,567) 2,422 (2,353–2,493) 2,433 (2,358–2,511) 2,358 (2,270–2,448) 0.15
sICAM-1
(ng/ml)
Model 1* 300 (291–310) 303 (293–313) 300 (290–311) 303 (292–314) 293 (282–304) 0.31
Model 2† 303 (291–316) 304 (294–315) 300 (290–311) 302 (291–314) 291 (279–303) 0.13
Model 3‡ 301 (288–315) 304 (293–315) 300 (290–311) 302 (291–314) 292 (278–305) 0.29
sVCAM-1
(ng/ml)
Model 1* 695 (673–718) 677 (655–699) 673 (651–695) 675 (652–699) 665 (642–689) 0.06
Model 2† 703 (676–731) 680 (657–703) 673 (651–696) 673 (650–697) 660 (634–686) 0.05
Model 3‡ 707 (678–738) 681 (658–704) 673 (651–696) 671 (648–696) 656 (628–685) 0.04
E-selectin
(ng/ml)
Model 1* 45.5 (43.2–47.8) 42.5 (40.4–44.7) 40.8 (38.8–43.0) 40.8 (38.7–43.1) 40.7 (38.5–43.0) 0.0007
Model 2† 43.9 (41.2–46.7) 41.9 (39.8–44.1) 40.7 (38.6–42.9) 41.3 (39.1–43.6) 41.8 (39.4–44.5) 0.43
Model 3‡ 43.8 (41.0–46.8) 41.9 (39.7–44.2) 40.7 (38.7–42.9) 41.4 (39.1–43.8) 42.1 (39.4–45.1) 0.62
Dataareadjustedgeometricmeans(95%CI).*Model1adjustedformatchingfactors(age,race/ethnicity,clinicalcenter,andtimeofblooddraw),smoking,alcohol,
total energy expenditure from recreational physical activity/week, total energy intake, BMI, and case-control status. †Model 2 adjusted for variables in model 1 plus
dietary ﬁber intake. ‡Model 3 adjusted for variables in model 2 plus fruit and vegetable intake, folate intake, and total saturated and trans fat intake. Q, quintile.
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withdietarymagnesiumintakebeforead-
justment for dietary ﬁber intake, this re-
lation was attenuated after adjustment,
suggesting that the inverse association
withTNF--R2ismostlikelypartiallyex-
plained by the association with dietary
ﬁber.
With regard to endothelial dysfunc-
tion,weobservedthatdietarymagnesium
wasinverselyassociatedwithplasmacon-
centrations of sVCAM-1 independently
of other dietary factors. sVCAM-1 and
sICAM-1 are cellular adhesion molecules
belonging to the immunoglobulin family
and are primarily involved in the attach-
ment and transendothelial migration of
leukocytes in response to inﬂammatory
cytokines (24). We observed no associa-
tion between dietary magnesium intake
and plasma concentrations of sICAM-1, a
ﬁnding consistent with a cross-sectional
study in the Nurses’ Health Study (6).
However, we observed a modest associa-
tion with sVCAM-1 that remained signif-
icant even after adjustment for dietary
factors associated with endothelial dys-
function and cardiovascular disease. Al-
though the biological explanation for the
variability in results across markers is not
clear, these ﬁndings further support the
link between low magnesium intake and
elevated concentrations of certain mark-
ers of endothelial dysfunction. E-selectin
is a cellular adhesion molecule found pri-
marily on the surface of stimulated endo-
thelialcellsandmediatestheinitialrolling
ofleukocytesalongtheendothelium(25).
In the current study, we observed an in-
verse association of dietary magnesium
intakewithE-selectinthatdisappearedaf-
ter we accounted for dietary factors.
In this multiethnic cohort of women,
we observed notable variation in strengths
of association across ethnicity. To our
Table3—Linearregressioncoefﬁcientsfortherelationbetweeneachincreaseof100mg/dayindietarymagnesiumintakeandlog-transformed
biomarkers of inﬂammation and endothelial dysfunction among postmenopausal women in the WHI-OS
Ethnicity and biomarkers
Dietary magnesium
Model 1* Model 2† Model 3‡
All (n  3,713)
hs-CRP (mg/l) 0.12  0.04 (0.004)§ 0.17  0.06 (0.006) 0.23  0.07 (0.002)
IL-6 (pg/ml) 0.15  0.03 (0.0001) 0.12  0.04 (0.005) 0.14  0.05 (0.004)
TNF--R2 (pg/ml) 0.04  0.01 (0.0004) 0.04  0.02 (0.02) 0.04  0.02 (0.06)
sICAM-1 (ng/ml) 0.01  0.01 (0.30) 0.04  0.02 (0.05) 0.03  0.02 (0.15)
sVCAM-1 (ng/ml) 0.02  0.01 (0.13)‡ 0.04  0.02 (0.05) 0.04  0.02 (0.07)
E-selectin (ng/ml) 0.07  0.02 (0.0005) 0.02  0.03 (0.47) 0.01  0.03 (0.71)
White (n  1,922)
hs-CRP (mg/l) 0.07  0.05 (0.13) 0.16  0.07 (0.03) 0.27  0.09 (0.004)
IL-6 (pg/ml) 0.14  0.04 (0.0001) 0.09  0.05 (0.08) 0.19  0.07 (0.006)
TNF--R2 (pg/ml) 0.06  0.01 (0.0001) 0.05  0.02 (0.03) 0.04  0.03 (0.13)
sICAM-1 (ng/ml) 0.03  0.01 (0.01) 0.02  0.02 (0.37) 0.02  0.02 (0.41)
sVCAM-1 (ng/ml) 0.03  0.02 (0.07) 0.02  0.02 (0.38) 0.03  0.03 (0.30)
E-selectin (ng/ml) 0.09  0.03 (0.0003) 0.04  0.04 (0.25) 0.03  0.05 (0.48)
African American (n  1,123)
hs-CRP (mg/l) 0.17  0.07 (0.02) 0.21  0.11 (0.06) 0.34  0.14 (0.01)
IL-6 (pg/ml) 0.18  0.05 (0.0006) 0.11  0.08 (0.16) 0.17  0.10 (0.08)
TNF--R2 (pg/ml) 0.02  0.02 (0.37) 0.007  0.03 (0.83) 0.008  0.04 (0.83)
sICAM-1 (ng/ml) 0.009  0.04 (0.79) 0.08  0.05 (0.12) 0.08  0.07 (0.21)
sVCAM-1 (ng/ml) 0.02  0.02 (0.50) 0.04  0.04 (0.24) 0.03  0.04 (0.42)
E-selectin (ng/ml) 0.05  0.03 (0.13) 0.01  0.05 (0.80) 0.02  0.06 (0.79)
Hispanic (n  423)
hs-CRP (mg/l) 0.12  0.10 (0.25) 0.16  0.16 (0.34) 0.07  0.20 (0.73)
IL-6 (pg/ml) 0.07  0.08 (0.43) 0.16  0.13 (0.21) 0.03  0.16 (0.87)
TNF--R2 (pg/ml) 0.04  0.03 (0.19) 0.09  0.05 (0.05) 0.09  0.06 (0.12)
sICAM-1 (ng/ml) 0.04  0.03 (0.20) 0.06  0.05 (0.22) 0.01  0.06 (0.85)
sVCAM-1 (ng/ml) 0.01  0.04 (0.71) 0.10  0.06 (0.12) 0.14  0.08 (0.07)
E-selectin (ng/ml) 0.07  0.06 (0.22) 0.05  0.09 (0.55) 0.07  0.11 (0.51)
Asian/Paciﬁc Islander (n  245)
hs-CRP (mg/l) 0.14  0.34 (0.68) 0.04  0.52 (0.94) 0.23  0.65 (0.72)
IL-6 (pg/ml) 0.36  0.14 (0.01) 0.33  0.21 (0.12) 0.48  0.27 (0.07)
TNF--R2 (pg/ml) 0.04  0.05 (0.39) 0.001  0.07 (0.98) 0.02  0.09 (0.81)
sICAM-1 (ng/ml) 0.08  0.05 (0.11) 0.03  0.08 (0.73) 0.12  0.09 (0.19)
sVCAM-1 (ng/ml) 0.02  0.06 (0.71) 0.06  0.09 (0.48) 0.07  0.11 (0.52)
E-selectin (ng/ml) 0.09  0.09 (0.30) 0.22  0.13 (0.09) 0.44  0.16 (0.008)
Data are means  SEM (P). n  3,713. *Model 1 adjusted for matching factors (age, race/ethnicity, clinical center, and time of blood draw), smoking, alcohol, total
energy expenditure/week, total energy intake, BMI, and case-control status. †Model 2 adjusted for variables in model 1 plus dietary ﬁber. ‡Model 3 adjusted for
variables in model 2 plus fruit, vegetable, folate intake, and total saturated and trans fat intake. §P values are from multiple linear regression models for the relation
between dietary magnesium intake (per 100 mg/day increase) and log-transformed biomarkers.
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ined potential ethnic differences in the rela-
tion of magnesium intake to systemic
inﬂammation and endothelial dysfunction.
Our ﬁndings of possible interactions in the
current study should be interpreted with
caution (i.e., hypothesis-generating) be-
cause ethnicity-speciﬁc sample sizes were
small and the differences could partially be
due to residual confounding from demo-
graphic and lifestyle factors. More impor-
tantly, the generally consistent patterns
across the four ethnic groups provide addi-
tional evidence to support the notion that
increasedmagnesiumintakemayhaveben-
eﬁcial effects on alleviation of systemic in-
ﬂammation and endothelial dysfunction.
We also observed stronger associations of
dietarymagnesiumintakewithhs-CRPand
IL-6 concentrations among subgroups with
the highest concentrations of these inﬂam-
matory markers, i.e., overweight women
and smokers. Similar ﬁndings among these
high-risk subgroups were reported in the
Women’s Health Study (1), suggesting that
highermagnesiumintakemaybemostben-
eﬁcial among women who are predisposed
to systemic inﬂammation.
There are several limitations that
merit consideration. First, the measure-
mentofdietarymagnesiumintakemaybe
inaccuratebecauseofself-reportinconsis-
tencies; however, magnesium intake as-
sessedbyourFFQhasacorrelationof0.7
when validated against dietary records
(17). Furthermore, in analyses that cor-
rectedformeasurementerror,therelation
betweenmagnesiumintakeandbiomark-
ers was strengthened. Second, dietary
magnesium intake is highly correlated
with several nutrients including dietary
ﬁber, potassium, and folate, and magne-
sium is found in high concentrations in
foods such as whole grains, nuts, and
fruits and vegetables. Therefore, parsing
out the independent effects of dietary
magnesium is a challenge. In the current
study, we sought to examine the indepen-
dent effects of dietary magnesium through
adjustment for dietary ﬁber as well as fruit
and vegetable intake, folate intake, and
saturated and trans fat intake in multiva-
riable-adjusted models to control for po-
tentialconfounding.Ourﬁndingssuggest
that dietary magnesium is associated with
several markers of inﬂammation and en-
dothelial dysfunction independent of
these dietary factors, although we could
not completely exclude the possibility of
residual confounding. This, coupled with
the cross-sectional design, does limit our
ability to make causal inferences regard-
ing the effect of magnesium intake on
markers of inﬂammation and endothelial
dysfunction.
In summary, we found that dietary
intake of magnesium was independently
and inversely associated with plasma
concentrations of hs-CRP, IL-6, and
sVCAM-1 in postmenopausal women.
These ﬁndings are consistent with those
of previous studies mostly in whites and
supportthenotionthatdietshighinmag-
nesium-rich foods including whole
grains, nuts, and leafy green vegetables
should be encouraged for metabolic dis-
ease prevention.
Figure1—Multivariableadjustedmeansofhs-CRP(mg/l)andIL-6(pg/ml)acrossincreasingquintilesofdietarymagnesiumstratiﬁedbyBMI(BMI
25 kg/m
2 [n  1,047] and BMI 25 kg/m
2 [n  2,666]) (A and B) and smoking status (never smokers [n  1,959] and ever smokers [including
past and current smokers, n  1,707]) (C and D). Models are adjusted for matching factors (age, race/ethnicity, clinical center, and time of blood
draw), smoking, alcohol, total energy expenditure/week, total energy intake, BMI, type 2 diabetes status, dietary ﬁber intake, fruit and vegetable
intake, folate intake, and trans and saturated fat intake (model 3). Tests of linear trend were conducted by using the median value of each quintile
as a continuous variable in the model.
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